Evaluating a mobile health tool to improve management of pediatric acute respiratory illness in Uganda
评估移动医疗工具以改善乌干达儿科急性呼吸道疾病的管理
基本信息
- 批准号:10704533
- 负责人:
- 金额:$ 18.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-15 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:Active LearningAcuteAddressAdherenceAdoptionAfrica South of the SaharaAntibioticsAsthmaBreathingBronchiolitisBronchodilator AgentsCase ManagementCategoriesCessation of lifeChestChildChildhoodChronic DiseaseClinical effectivenessCollaborationsCommunity Health AidesComplexConsolidated Framework for Implementation ResearchCoughingDataDevelopment PlansDiagnosisDiseaseEducationEffectivenessEnvironmentEpidemiologyEvaluationFeasibility StudiesFocus GroupsGoalsGrantGuideline AdherenceGuidelinesHealthImpact evaluationInformation SciencesInfrastructureIntegrated Health Care SystemsInternationalInterruptionInterventionInterviewLeadershipLifeLungMapsMaster of ScienceMeasuresMentored Clinical Scientist Development ProgramMentorshipMethodsMorbidity - disease rateNational Heart, Lung, and Blood InstituteOutcomeOutcome AssessmentOutcome MeasurePenetrationPhysiciansPneumoniaPragmatic clinical trialPrevention strategyProcessPublic HealthPublic Health SchoolsQuasi-experimentRecommendationResearchResearch ActivityResearch PersonnelResource-limited settingResourcesRunningSeriesSurveysSymptomsSystems IntegrationTestingTimeTrainingTraining ActivityTriageUgandaUniversitiesWashingtonWheezingWorld Health Organizationagedcare deliverycareer developmentclinical careclinical decision supportcollegecostdesignevidence baseexperienceglobal healthimplementation determinantsimplementation facilitationimplementation outcomesimplementation researchimplementation scienceimplementation strategyimprovedimproved outcomelow and middle-income countriesmHealthmedical schoolsmortalityparticipant retentionpediatric health outcomespilot testpoint of carepragmatic trialpreferenceprimary outcomeprototyperespiratoryskillssmartphone applicationsupport toolstooltreatment strategytrial designusability
项目摘要
Candidate: Dr. Ellington is a pediatric pulmonologist at the University of Washington (UW) and K12
UW-Implementation Science Training Grant recipient (NHLBI). She completed a Master of Science in
Epidemiology at the UW School of Public Health and has a long-term track record of successful global
health research. Dr. Ellington’s long-term goal is to become an independent physician-investigator
working to improve health outcomes of pediatric respiratory conditions in resource-constrained settings.
Her career development plan includes coursework, experiential learning, and mentorship to achieve
training goals in 1) complex qualitative and mixed methods, 2) pragmatic clinical trials and quasi-
experimental studies, 3) advanced implementation science, and 4) global health leadership.
Environment: The proposed training and research activities will be facilitated by existing strong
international collaborations, resources, infrastructure, and academically rigorous environments of the
UW Schools of Medicine and Public Health and the Makerere University Lung Institute and College of
Computing & Information Science. Research: Acute lower respiratory illnesses (ALRI) are a leading
cause of childhood mortality in children under 5 years, despite effective prevention and treatment
strategies. The majority of deaths occur in sub-Saharan Africa. Major challenges in case management
exist in low- and middle-income countries (LMICs), including poor adherence to ALRI guidelines, lack
of health worker training, and lack of decision support to recognize wheezing illnesses (asthma and
bronchiolitis), which represent up to 50% of ALRI in children. Acute Lower Respiratory Illness Treatment
Evaluation (ALRITE) is a comprehensive guideline- and evidence-based ALRI clinical decision support
mobile health tool Dr. Ellington developed with her team. ALRITE has demonstrated preliminary
acceptability and usability in Ugandan health centers but requires optimization for health system
integration and pilot-testing in clinical care. Dr. Ellington proposes a feasibility study in 4 Ugandan
health centers to 1) identify promising implementation strategies for the ALRITE intervention to optimize
implementation, 2) pilot-test study feasibility of the ALRITE tool and its effectiveness for diagnosis and
management of wheezing illness and pneumonia in children 1-59 months using an interrupted time
series design, and 3) assess the outcomes of implementation following ALRITE deployment and
barriers/facilitators of ALRITE use. Successful completion of these aims will improve implementation of
decision support tools in Uganda and other LMICs, provide critical preliminary data to support Dr.
Ellington’s planned R01 for a cluster RCT evaluating clinical effectiveness of the ALRITE intervention
in LMICs, and provide Dr. Ellington with the training and experience needed to transition to research
independence.
候选人:Ellington 博士是华盛顿大学 (UW) 和 K12 的儿科肺科医生
她获得了威斯康星大学实施科学培训补助金 (NHLBI) 的理学硕士学位。
华盛顿大学公共卫生学院流行病学专业,在全球范围内取得成功的长期记录
艾灵顿博士的长期目标是成为一名独立的医生研究员。
致力于改善资源有限环境中儿科呼吸系统疾病的健康结果。
她的职业发展计划包括课程作业、体验式学习和指导,以实现
培训目标 1) 复杂的定性和混合方法,2) 实用的临床试验和准
实验研究,3) 先进的实施科学,4) 全球卫生领导力。
环境:拟议的培训和研究活动将由现有的强大的
国际合作、资源、基础设施和严谨的学术环境
威斯康星大学医学与公共卫生学院和麦克雷雷大学肺脏研究所和学院
计算与信息科学研究:急性下呼吸道疾病 (ALRI) 是一个领先的领域。
尽管预防和治疗有效,但仍导致 5 岁以下儿童死亡
大多数死亡发生在撒哈拉以南非洲地区。
低收入和中等收入国家 (LMIC) 中存在这些问题,包括对 ALRI 指南的遵守情况不佳、缺乏
卫生工作者培训不足,缺乏识别喘息疾病(哮喘和哮喘)的决策支持
细支气管炎),占儿童急性下呼吸道疾病治疗的 50%。
评估 (ALRITE) 是一项全面的基于指南和证据的 ALRI 临床决策支持
Ellington 博士与她的团队开发的移动健康工具 ALRITE 已进行了初步展示。
乌干达卫生中心的可接受性和可用性,但需要优化卫生系统
Ellington 博士提议在乌干达开展一项可行性研究。
卫生中心 1) 确定有前景的 ALRITE 干预实施策略,以优化
实施,2) ALRITE 工具的可行性及其诊断和有效性的试点研究
使用中断时间管理 1-59 个月儿童的喘息疾病和肺炎
系列设计,3) 评估 ALRITE 部署后的实施结果
成功完成这些目标将改善 ALRITE 使用的障碍/促进因素。
乌干达和其他中低收入国家的决策支持工具提供了关键的初步数据来支持博士。
Ellington 计划进行 R01 集群随机对照试验,评估 ALRITE 干预的临床效果
中低收入国家,并为艾灵顿博士提供过渡到研究所需的培训和经验
独立。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laura E Ellington其他文献
Laura E Ellington的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laura E Ellington', 18)}}的其他基金
Evaluating a mobile health tool to improve management of pediatric acute respiratory illness in Uganda
评估移动医疗工具以改善乌干达儿科急性呼吸道疾病的管理
- 批准号:
10426760 - 财政年份:2022
- 资助金额:
$ 18.49万 - 项目类别:
相似国自然基金
巨噬细胞Nogo-B通过FABP4/IL-18/IL-18R调控急性肝衰竭的分子机制研究
- 批准号:82304503
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于解郁散热“把好气分关”探讨代谢-炎症“开关”A2BR在急性胰腺炎既病防变中的作用与机制
- 批准号:82374256
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
RacGAP1介导细胞核-线粒体对话在急性肾损伤中促进肾小管上皮细胞能量平衡的作用机制研究
- 批准号:82300771
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
开窍寒温配伍调控应激颗粒铁离子富集水平抗急性缺血性卒中铁死亡损伤的机制研究
- 批准号:82374209
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Repurposing RET Inhibitors for Endocrine Resistant Breast Cancer
重新利用 RET 抑制剂治疗内分泌耐药乳腺癌
- 批准号:
10644068 - 财政年份:2023
- 资助金额:
$ 18.49万 - 项目类别:
BEATS: Binge drinking Ecological Antecedents with Transdermal alcohol monitoring Study.
BEATS:通过透皮酒精监测研究暴饮暴食的生态前因。
- 批准号:
10827305 - 财政年份:2023
- 资助金额:
$ 18.49万 - 项目类别:
Beyond Treatment Initiation: Enhancing Opioid Use Disorder Care Transitions Across Health System Touchpoints
除了治疗启动之外:加强阿片类药物使用障碍护理在卫生系统接触点的转变
- 批准号:
10592062 - 财政年份:2023
- 资助金额:
$ 18.49万 - 项目类别:
Insomnia and Physical Function in Older Veterans During and After CLC Rehabilitation Admission
老年退伍军人 CLC 康复入院期间和之后的失眠和身体功能
- 批准号:
10746207 - 财政年份:2023
- 资助金额:
$ 18.49万 - 项目类别: